November 2017

Sun Mon Tue Wed Thu Fri Sat
02/11/2017 - 14:00 to 15:00
07/11/2017 - 12:00 to 13:00
08/11/2017 - 09:30 to 10/11/2017 - 17:00
08/11/2017 - 10:00 to 15:00
08/11/2017 - 09:30 to 10/11/2017 - 17:00
15/11/2017 - 14:00 to 16:00
16/11/2017 - 09:00 to 16:00
17/11/2017 - 12:00 to 14:00
17/11/2017 - 15:00 to 17:00
21/11/2017 - 09:00 to 22/11/2017 - 17:00
21/11/2017 - 09:00 to 22/11/2017 - 17:00
24/11/2017 - 10:30 to 12:00
30/11/2017 - 15:00 to 16:00


24/10/2016 - 09:00

RCaH's Royal Society exhibit travels to Manchester Science Festival as a satellite exhibition.

24/10/2016 - 10:00

A cross EPSRC review session with CCPi representation from

29/10/2016 - 09:00

NSS/MIC venue to showcase outstanding developments and contributions across the nuclear and medical instrumentation fields.


03/11/2016 - 19:00

2016 STIR Users' & Developers’ Meeting is available: This year the event will take place on Thursday, 3 November, 19:00-21:00 in Strasbourg (France) during the IEEE NSS-MIC ( - Room Varsovie, Palais de la Musique et des Congrès. Please, register your interest in attending:

09/11/2016 - 12:00

Speaker: Dr. Nicolas A Karakatsanis from the Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York

PET imaging seminar that will take place at the University of Leeds (Seminar Room 8.34b, Worsley Building, Clarendon Way, LS2 9NL) at 12-1pm on Wednesday, 9/11.

Abstract: Positron emission tomography (PET) allows for non-invasive in-vivo quantitative imaging of particular molecular processes underlying physiology and diseases by employing each time a specific positron emitting radio-tracer. In addition, current state-of-the-art clinical systems are capable of simultaneous PET and Magnetic Resonance (MR) data acquisitions to permit ideal spatial and temporal co-registration between the two imaging modalities in clinically acceptable total scan time periods and thus utilize the superior soft tissue contrast and absence of radiation of MR to facilitate the more accurate localization and clinical interpretation of the PET signal at low radiation exposure levels. Nevertheless, MR is currently associated with limited capabilities in determining the anatomical bone tissues thereby degrading PET signal quantification in proximity to bone tissues.

In this talk we are going to introduce the novel concept of dual-tracer 18F-FDG:18F-NaF dynamic PET/MR framework to facilitate i) improved accuracy in MR-based PET attenuation correction over and near the bone tissues, and ii) decoupling within a single PET/MR session of the individual PET images of 18F-FDG and 18F-NaF cocktail tracer components, each previously shown to be associated with the atherosclerotic disease processes of inflammation and micro-calcification, respectively. Initially, the clinical value of the 18F-NaF component will be demonstrated in driving the segmentation of the bone tissues for improved MR-based attenuation correction maps and PET signal quantification. Later, the clinical feasibility of discriminating the two individual PET tracer component images from the acquired dual-tracer PET/MR data will be illustrated for a 90min 18F-FDG:18F-NaF PET/MR human carotid study. In both dual-tracer dynamic PET/MR application contexts, the critical role of various design parameters of the imaging protocol will be discussed, including the relative concentration ratio as well as the administration and circulation times between the two cocktail PET tracer component dosages.  
Short Bio
Dr. Nicolas A. Karakatsanis is currently a Postdoctoral Research Scientist at the Translational and Molecular Imaging Institute at Icahn School of Medicine at Mount Sinai Hospital, New York, NY. His current interests focus mainly on truly quantitative whole-body PET parametric imaging utilizing advanced kinetic modeling and motion compensation strategies for enhancing the theranostic value of clinical PET/MR and PET/CT multi-modality imaging particularly in oncology and cardiology. Previously, he was appointed as a research associate in the Division of Nuclear Medicine at University Hospital of Geneva, Switzerland (2014-2015) and the Division of Nuclear Medicine at Johns Hopkins University Hospital, Baltimore, MD, USA (2011-2013). As an external scientific advisor, he maintains a close and active collaboration with the previous institutions leading or participating in a number of on-going medical imaging research projects. Dr. Karakatsanis received his Bachelor and Masters joint Diploma as well as his PhD in Electrical and Computer Engineering in 2005 and 2010, respectively, from the National Technical University of Athens, Greece. His PhD thesis was on the optimization of Positron Emission Tomography (PET) imaging systems performance and data acquisition protocols using Monte Carlo simulations. He has co-authored more than 18 articles in international refereed journals and over 60 articles in peer-reviewed conference proceedings. He is a member of Nuclear Medicine and Molecular Imaging (SNMMI) as well as the IEEE Nuclear Plasma and Sciences (NPSS) societies. Dr. Karakatsanis has been certified by the American Board of Science in Nuclear Medicine (ABSNM).

For updated info:


09/11/2016 - 15:00

CCPi data and code demonstrations for schools for potential collaboration. Held in Manchester.